[Pineal region tumors in children: is gross-total resection necessary? A single-center experience]

Enrique López-Aguilar1, María del Carmen Garza-González, Mariana Ortiz-Azpilcueta

  • 1Jefatura de Servicio de Oncología, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Distrito Federal, México. elopezaguilar@hotmail.com.

Insights

Biopsy followed by chemotherapy and radiotherapy offers better survival for children with pineal region tumors compared to gross resection. This approach reduces mortality and endocrine complications in pediatric patients.

Area of Science:

  • Pediatric Oncology
  • Neurosurgery
  • Endocrinology

Background:

  • Pineal region tumors in children are associated with significant endocrine disorders, morbidity, and mortality, particularly after aggressive surgical resection.
  • Survival rates for pediatric pineal region tumors have improved, yet outcomes remain challenging.

Purpose of the Study:

  • To analyze survival, outcomes, morbidity, and mortality in pediatric patients with pineal region tumors.
  • To compare the effects of different surgical approaches (gross resection vs. biopsy) and treatments on patient outcomes.

Main Methods:

  • Retrospective analysis of pediatric patients (≤17 years) diagnosed with pineal region tumors over a 10-year period.
  • Inclusion of histopathological review and assessment of the extent of surgical resection.
  • Estimation of patient survival rates.

Main Results:

  • Out of 46 patients, 36 had complete data. Gross resection was performed in 66.6% and biopsy in 33.3%.
  • Ten-year survival rates were 52% for gross resection and 75% for biopsy (p=0.7).
  • Endocrine alterations occurred in 36.1% of patients, with 76.9% of these having undergone total resection.

Conclusions:

  • Diagnostic biopsy followed by adjuvant chemotherapy and radiotherapy is a viable treatment strategy for pediatric pineal region tumors.
  • Minimally invasive surgical approaches may be associated with better outcomes and reduced endocrine complications.
  • Further research is needed to optimize treatment protocols for these rare pediatric tumors.
Abstract

Related Concept Videos